New Discoveries in Colorectal Cancer: Bacteria’s Role in Colorectal Cancer Development

▴ Bacteria’s Role in Colorectal Cancer Development
The study sheds light on a specific bacterium’s role in shielding tumour cells from cancer-fighting drugs, a finding that could revolutionize therapeutic approaches.

In a shocking discovery, scientists have identified a bacterium that could potentially contribute to the rise in colon or colorectal cancer cases. Published in the prestigious journal Nature, the study sheds light on a specific bacterium’s role in shielding tumour cells from cancer-fighting drugs, a finding that could revolutionize therapeutic approaches and early screening methods for colorectal cancer.

Conducted by researchers from the Fred Hutch Cancer Centre in the US, the study revealed that this particular bacterium was present in 50% of the tumours analysed. The bacterium, known as Fusobacterium nucleatum, is commonly found in the mouth but can travel to the gut and thrive within colon cancer tumours.

The study, which examined colorectal cancer tumours removed from 200 patients, found increased levels of Fusobacterium nucleatum in about 50% of cases compared to healthy tissue. Additionally, stool samples from colon cancer patients contained higher quantities of this microbe compared to samples from healthy individuals.

Dr. Susan Bullman, a cancer microbiome researcher and co-corresponding study author, emphasized the association between colorectal tumours containing Fusobacterium nucleatum and poor patient outcomes. Patients with these tumours often exhibit lower survival rates and prognosis compared to those without the bacterium.

Further analysis revealed that Fusobacterium nucleatum in colorectal tumours consists of two distinct lineages or “clades.” Of these, the Fna C2 subtype displayed genetic traits enabling it to travel from the mouth to the lower gastrointestinal tract, where it promotes cancer growth. The researchers identified 195 genetic differences between these clades, with the Fna C2 subtype significantly enriched in colorectal tumour tissue.

This ground-breaking research not only highlights the potential link between Fusobacterium nucleatum and colorectal cancer but also highlights the importance of understanding the microbiome’s role in cancer development and progression. By identifying specific bacterial strains associated with cancer growth, scientists can develop targeted interventions and treatment strategies to improve patient outcomes.

Moving forward, further research is needed to elucidate the mechanisms by which Fusobacterium nucleatum contributes to colorectal cancer progression. Additionally, exploring preventive measures and early detection methods could aid in mitigating the impact of this bacterium on cancer development.

As scientists continue to discover the complexities of the microbiome and its implications for human health, studies like these lead the way for innovative approaches to cancer prevention, diagnosis, and treatment. By leveraging the power of scientific research and collaboration, we can strive towards a future where colorectal cancer is not only treatable but preventable, ultimately saving lives and improving patient well-being

Tags : #

About the Author


Sunny Parayan

Hey there! I'm Sunny, a passionate writer with a strong interest in the healthcare domain! When I'm not typing on my keyboard, I watch shows and listen to music. I hope that through my work, I can make a positive impact on people's lives by helping them live happier and healthier.

View Profile

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

HR leaders ready to shape India's future workforce - XLRI and Leadup Universe seminar in PuneNovember 05, 2024
Nestlé India and SM Sehgal Foundation celebrate 5 years of Project Vriddhi November 05, 2024
Why Tuberculosis Is Still the World’s Leading Killer in 2024 And How We’re Failing to Stop ItNovember 05, 2024
Crompton Launches the Nigella Pro Mixer Grinder to Revolutionize Kitchen ConvenienceNovember 05, 2024
Invisible Shadows: The Growing Crisis of Corneal Blindness in IndiaNovember 05, 2024
Thai AirAsia Entrusts Çelebi India with Ground Handling for New Hyderabad- Bangkok Flights, Signalling Further India Expansion November 05, 2024
Thai AirAsia Entrusts Çelebi India with Ground Handling for New Hyderabad- Bangkok Flights, Signalling Further India Expansion November 05, 2024
Discover 5 Platforms That Turn Your Pennies into PowerhousesNovember 04, 2024
Breathless in the Capital: Post-Diwali Smog Triggers Health Alarms in DelhiNovember 04, 2024
Is Your Diet Fuelling Your Disease? The Shocking Link Between Oil and Multiple SclerosisNovember 04, 2024
Unmasking the Danger Within: The Alarming Rise of Stomach Cancer in IndiaNovember 04, 2024
Hospital-acquired infections are fuelling antimicrobial resistance October 30, 2024
Transforming Patient Care: HealthTech Startups Making Waves in HealthcareOctober 30, 2024
Hospital-acquired infections are fuelling antimicrobial resistance October 30, 2024
Impressive Growth & Margin Expansion 237% YoY Surge in Net ProfitsOctober 29, 2024
Ramaiah Memorial Hospital Announces the Launch of its Comprehensive State-of-the-art Ramaiah Stroke Center on World Stroke Day October 29, 2024
CarDekho Group's New Auto Segment’s Festive Trend Report: SUVs Lead the Way with a 43% YoY Traffic Increase Across All Sub-SegmentsOctober 29, 2024
World Stroke Day by Dr Praveen Gupta, Principle Director and Chief of Neurology, Fortis Hospital.October 29, 2024
HighTide Therapeutics to Present Analyses of Phase 2 MASH Study at AASLD's The Liver Meeting 2024October 29, 2024
AI Gone Wild? Why OpenAI’s Whisper - Transcription Tool used in Hospitals Might Be Putting Lives at RiskOctober 29, 2024